E Bruguera Cortada, GN Rifà // Tabaquismo y patología psiquiátrica • Himelhoch, S., Leith, J., Goldberg, R., Kreyenbuhl, J., Medoff, D., & Dixon, L. (2009). Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. General Hospital Psychiatry, 31(1), 30–32. • Hughes, J. R. (2008). Smoking and suicide: a brief overview. Drug and Alcohol Dependence, 98(3), 169–178. • Hughes, J. R. (2013). An updated algorithm for choosing among smoking cessation treatments. Journal of Substance Abuse Treatment, 45(2), 215–21. • Kalman, D., Morissette, S. B., & George, T. P. (2005). Co-Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders. Am J Addict, 14(2), 106–123. • Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J., & Kessler, R. C. (1993). Smoking and major depression. A causal analysis. Archives of General Psychiatry, 50(1), 36–43. • Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. The American Journal of Psychiatry, 142(11), 1259–64. • Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. • Khantzian, E. J. (2013). Addiction as a self-regulation disorder and the role of self-medication. Addiction. 4. • Kreinin, A., Novitski, D., Rabinowitz, D., Weizman, A., & Grinshpoon, A. (2012). Association between tobacco smoking and bipolar affective disorder: Clinical, epidemiological, cross-sectional, retrospective study in outpatients. Comprehensive Psychiatry, 53(3), 269–274. • Kumari, V., & Postma, P. (2005). Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience and Biobehavioral Reviews. • Lader, D., & Goddard, E. (2004). Smoking-related Behaviour and Attitudes, 2004. London. • Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. JAMA: The Journal of the American Medical Association, 284(20), 2606–2610. • Manzella, F., Maloney, S., & Taylor, G. (2015). Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World Journal of Psychiatry, 22(5), 35–46. • McClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2010). Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. American Journal of Public Health, 100(12), 2464–72. • McCreadie, R. G. (2003). Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study Diet, smoking and cardiovascular risk in people with schizophrenia Descriptive study. The British Journal of Psychiatry, 183, 534–539. • Meltzer, H., Gill, B., Hinds, K., & Petticrew, M. (1996). OPCS Surveys of PsychiatricMorbidity in Great Britain, Report 6: Economic activity and social functioning of residents with psychiatric disorders. London. • Miller, M., Hemenway, D., & Rimm, E. (2000). Cigarettes and suicide: a prospective study of 50,000 men. Am J Public Health, 90(5), 768–773. • Morisano, D., Bacher, I., Audrain-McGovern, J., & George, T. P. (2009). Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Canadian Journal of psychiatry.Revue Canadienne de Psychiatrie, 54(6), 356–367. • Office on Smoking and Health. (1994). Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Atlanta, GA. • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. (1996). The American Journal of Psychiatry, 153(10 Suppl), 1–31. • Practice guideline for the treatment of patients with substance use disorders. (2006). American Psychiatric Association. Washington DC. • Pratt, L. A., & Brody, D. J. (2010). Depression and smoking in the U.S. household population aged 20 and over, 2005- 2008. NCHS Data Brief, (34), 1–8. • Prochaska, J. J., Fletcher, L., Hall, S. E., & Hall, S. M. (2006). Return to smoking following a smoke-free psychiatric hospitalization. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 15(1), 15–22. • Prochaska, J. J., Gill, P., & Hall, S. M. (2004). Treatment of tobacco use in an inpatient psychiatric setting. Psychiatric Services (Washington, D.C.), 55(11), 1265–1270. EDITORIAL SCIENS 85
D Serebrisky // Trastornos por sustancias - Tabaco • Prochaska, J. J., Hall, S. E., & Hall, S. M. (2009). Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatric Services (Washington, D.C.), 60(6), 848. • Prochaska, J. J., Rossi, J. S., Redding, C. A., Rosen, A. B., Tsoh, J. Y., Humfleet, G. L., … Hall, S. M. (2004). Depressed smokers and stage of change: implications for treatment interventions. Drug and Alcohol Dependence, 76(2), 143–51. • Royal College of Physicians. (2013). Smoking and mental health. London. • Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, a, … Möller, H. J. (2014). EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry: The Journal of the Association of European Psychiatrists, 29(2), 65–82. • Schroeder, S. a, & Morris, C. D. (2010). Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annual Review of Public Health, 31, 297–314 1p following 314. • Siru, R., Hulse, G. K., & Tait, R. J. (2009). Assessing motivation to quit smoking in people with mental illness: a review. Addiction (Abingdon, England), 104(5), 719–33. • Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014). Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (Clinical Research Ed.), 348(feb13 1), g1151. • Taylor, T., Lader, D., Bryant, A., Keyse, L., & Joloza, M. (2006). Smoking-related behaviour and attitudes, 2005. London. • The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. (2014). Atlanta, GA. • Thomas, K. H., Martin, R. M., Knipe, D. W., Higgins, J. P. T., & Gunnell, D. (2015). Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ, 350(mar12 8), h1109–h1109. • Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012). A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. • Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., … Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco, 10(12), 1691–715. 86
Débora Serebrisky Fernando W. Mül
Índice Autores ...................
Recomendaciones para la intervenci
Autores Débora Serebrisky Médica
Gemma Nieva Rifà Doctora en psicol
Prólogo Buscando un cambio de para
EDITORIAL SCIENS 15
Capítulo 1 Neurofisiopatología de
D Serebrisky, FW Müller // Neurofi
D Serebrisky, FW Müller // Neurofi
D Serebrisky, FW Müller // Neurofi
D Serebrisky, FW Müller // Neurofi
D Serebrisky, FW Müller // Neurofi
D Serebrisky, FW Müller // Neurofi
Capítulo 2 Epidemiología del taba
AJ Videla Montilla // Epidemiologí
F Müller, D Serebrisky // Tratamie
Capítulo 12 Dejar de fumar sin eng
J Mociulsky // Dejar de fumar sin e
J Mociulsky // Dejar de fumar sin e
J Mociulsky // Dejar de fumar sin e
Loading...
Loading...
Loading...
Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar
Editorial Sciens, Todos los Derechos Reservados 2015